Related Experiment Video
Updated: Jun 17, 2025
00:06
An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
8.8K
New systemic treatment options for advanced cholangiocarcinoma
Valentina Zanuso1,2, Giulia Tesini1,2, Elena Valenzi1,2
1Department of Biomedical Sciences, Humanitas University, Milan, Italy.
Journal of Liver Cancer
|August 8, 2024
Summary
Advanced cholangiocarcinoma (CCA) treatment now includes immunotherapy alongside chemotherapy. Precision medicine targets specific genetic alterations, but its use remains limited, highlighting ongoing research needs.
Area of Science:
- Oncology
- Medical Research
Background:
- Cholangiocarcinoma (CCA) is a rare, aggressive cancer often diagnosed at advanced stages.
- Systemic treatment is the primary option for advanced or metastatic CCA.
- Chemotherapy has been the standard, with recent advances in immunotherapy.
Purpose of the Study:
- To review newly approved systemic therapies for advanced CCA.
- To discuss ongoing clinical studies and future research challenges.
- To provide an overview of precision medicine approaches in CCA.
Main Methods:
- Literature review of recent advancements in CCA systemic therapy.
- Analysis of clinical trial data for immunotherapy and targeted agents.
- Examination of comprehensive genomic profiling findings in CCA.
Main Results:
- Immune checkpoint inhibitors (durvalumab, pembrolizumab) combined with cisplatin plus gemcitabine are new first-line options.
- Immunotherapy efficacy is limited in later treatment lines, except for specific populations.
- Targetable genetic alterations (IDH1, FGFR2, HER2, BRAF, NTRK, RET, KRAS, MDM2) enable precision medicine.
Conclusions:
- The treatment landscape for advanced CCA has evolved with immunotherapy and targeted therapies.
- Precision medicine offers promise but is currently applicable to a subset of patients.
- Further research is crucial to address challenges and improve outcomes in advanced CCA management.
Related Concept Videos
01:29Chronic Pancreatitis II: Collaborative Care
79
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
79
01:27Tumor Immunotherapy
497
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
497
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
02:49Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K